Barnett & Company, Inc. Novo Nordisk A S Transaction History

Barnett & Company, Inc.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2020 Jul 22, 2020	SELL	$58.54 - $67.94 $37,582 - $43,617	-642 Closed	0 $0
Q1 2020 Apr 23, 2020	SELL	$49.46 - $64.78 $2,819 - $3,692	-57 Reduced 8.15%	642 $39,000
Q4 2019 Jan 22, 2020	BUY	$49.86 - $58.26 $32,010 - $37,402	642 Added 1126.32%	699 $40,000
Q3 2019 Nov 12, 2019	BUY	$47.54 - $53.43 $2,709 - $3,045	57 New	57 $3,000

1,884

336M

11.9M

10.6M

Ticker NVO
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 2,257,289,984
Market Cap $197B
Description
Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...

Get notified when there are updates to the investment portfolio of Barnett & Company, Inc., based on Form 13F filings with the SEC.

Stay updated on Barnett & Company, Inc. with notifications on news.